From India- THIS IS MAJOR

From India- THIS IS MAJOR

COVID-19 Cases Plummet in India as They Distribute Ivermectin and Hydroxychloroquine

 

UPDATED May 17, 2021 – State of Tamil Nadu halts use of Ivermectin. Just like that, despite Ivermectin saving lives, The Hindu is reporting that the state health department removed Ivermectin from its case management protocols. This is murder with malice, no matter how you slice it.

—ORIGINAL STORY—

the Covid blog,

16 May, 2021

NEW DELHI — India has received the baton for title of COVID Capitol of the World after China, Italy and the United States held it for much of last year.

The world second-most populace country after China had fewer than 138,000 total active COVID cases in early February 2021. That’s the lowest figure since January 2020. India active COVID cases sit around 3.6 million today, according to the India Ministry of Health and Family Welfare. Mainstream media are blaming the massive spike on a “scary, mutant variant” called B.1.617.

Said media are also speculating whether or not the “vaccines” will work against the variant. Only about 2.8% of India is vaccinated. Have no fear. Ivermectin and hydroxychloroquine are here.

The India health ministry updated its guidelines on April 28 for quarantines, treating the asymptomatic and those with mild symptoms of COVID-19. The agency now says that asymptomatic patients should “consider Tab Ivermectin (200 mcg/kg once a day, to be taken empty stomach) for 3 to 5 days.” Caregivers of patients in quarantine are instructed to “take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.” See the full document here.

World Health Organization, big pharma freak out

There are 292 studies (219 are peer-reviewed) proving the effectiveness of hydroxychloroquine as both a treatment and prophylaxis against COVID-19. Ivermectin has 93 studies (54 peer-reviewed) showing its effectiveness as treatment and prophylaxis against COVID-19. Despite the now-indisputable fact that these drugs essentially kill COVID-19 within hours or days, the Bill Gates-funded World Health Organization (WHO) and big pharma are having fits over India’s new guidelines and the results.

WHO Chief Scientist Soumya Swaminathan tweeted on May 10 that her organization recommends against the use of Ivermectin for COVID-19. She deleted the tweet shortly thereafter. Swaminathan, who happens to be Indian, cited a February press release from Merck, the company that discovered and once owned the long-expired patents on Stromectol (aka Ivermectin). The company wrote that there is “no meaningful evidence” and “no scientific basis” for using Ivermectin to treat and prevent COVID-19. Merck is one of the top donors to the CDC Foundation, as is the now-merged Pfizer/GlaxoSmithKline corporation.

The Canadian Global Television Network called Ivermectin and hydrochloroquine “two drugs that conspiracy theorists say cure COVID-19 and that scientists say are useless at treating the disease.” The Middle East North Africa Financial Network said there is “little evidence” of Ivermectin’s effectiveness. Times of India called both drugs “dangerous.”

COVID cases plummeting in India last two weeks

Dr. Pierre Kory is the chief medical officer of the Front Line Covid-19 Critical Care Alliance. Mainstream media label the good doctor as “misinformation.” He is best known for his Congressional testimony about Ivermectin. Dr. Kory did a live Zoom conference this week showing just how effective Ivermectin and hydroxychloroquine have been since India implemented the changes in its policies.

Here are the data from the state of Maharashtra in the two weeks since Ivermectin.

Here are the data from Delhi.

The same thing happened in Mexico when it started using Ivermectin.

Check out the full video below.

Indian State Will Offer Ivermectin To Entire Adult Population — Even As WHO Warns Against Its Use As Covid-19 Treatment

The World Health Organisation warned against the use of the anti-parasitic drug Ivermectin in treating Covid-19 on Tuesday after the Indian state of Goa announced it would give the drug to all its adult residents based on an unproven claim that it may help reduce the severity of Covid-19 infections.

KEY FACTS

  • The state health minister of Goa, Vishwajit Rane, said Monday that people will be given 12 mg of Ivermectin for a period of five days as prophylaxis to protect against Covid-19.
  • Rane claimed that the state government’s decision was based on studies by expert panels from the UK, Italy, Spain and Japan which found a statistically significant reduction in mortality and recovery time in patients with Covid-19, without offering any specifics. 
  • On Tuesday, the World Health Organisation’s Chief Scientist Dr. Soumya Swaminathan warned that the global health body recommends against the use of Ivermectin for COVID-19 except within clinical trials.
  • Goa—one of India’s smallest states by population—has witnessed a recent surge in Covid-19 cases and on Tuesday it reported 3,124 new cases and 75 fatalities on Tuesday evening.

 

Forbes,

11 May, 2021

BIG NUMBER

36%. That’s the percentage of test samples that returned a positive result in Goa on Tuesday. Goa’s daily positivity rate hovered around 50% last week and it continues to be the highest in the country, implying a lack of adequate testing.

CRUCIAL QUOTE

In its assessment of Ivermectin as a potential treatment for Covid-19, the U.S. National Institutes of Health noted that there is insufficient data for it to recommend the use of the drug, and added: “Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of COVID-19.”

KEY BACKGROUND

Ivermectin is approved at very specific doses for treating some parasitic worms but is not an anti-viral.  Peer-reviewed studies have shown mixed results with respect to Ivermectin and Covid-19 with some showing slight improvements while others suggesting that it has no effect. A report published in the journal Antiviral Research last year mentioned that Ivermectin “warrants further investigation for possible benefits in humans.” However further examination showed that the dosage required to achieve an antiviral effect is significantly higher than what has been approved for human use and it could possibly prove to be toxic. Since then, the U.S. Food and Drug Administration (FDA) has warned against using the anti-parasitic drug in treating Covid-19 as the evidence is not solid enough to come to a conclusion based on multiple small-scale studies. In March this year, the European Medicines Agency said that the available data does not support the use of Ivermectin for COVID-19 outside well-designed clinical trials. The EU body noted that results from clinical studies are varied and most of the studies reviewed by the EMA were small and had additional limitations.

TANGENT

The Goan chief minister Pramod Sawant and his government have faced criticism for failing to impose restrictions to control the spread of Covid-19 in the state. With sprawling beaches, Goa is one of India’s most popular holiday destinations with tourism being one of the state’s biggest economic contributors. However, even as the second wave of the pandemic spiraled out of control across the country Sawant and his government refused to shut down its beaches and casinos. Even as the neighboring state of Maharashtra quickly emerged as India’s Covid epicenter, Goa allowed its state borders to remain open. In a televised interview, the chief minister—who is a member of Prime Minister Narendra Modi’s right-wing BJP party—insisted that he could both run the economy and keep the pandemic in check. The tiny state has since seen a sharp rise in Covid-19 cases. The state’s high court intervened last week and ordered the government to ban the entry of travelers into the state without a negative test report. Since then Sawan’s government has moved to impose a so-called ‘stricter-than-lockdown’ curfew. The delay in implementing the measure, however, has severely that stretched the state’s hospital system. Early on Tuesday, 26 Covid-19 patients died at the state-run Goa Medical College and Hospital. Sawant who visited the facility admitted that the availability of medical oxygen and its supply to Covid-19 wards in the GMCH “might have caused some issues for the patients.”

Doctor Believes Ivermectin Drug Can Help India Stop Covid-19 Second Wave

  • Dr Surya Kant Tripathi, Head, Respiratory Medicine Department at King George Medical University in Lucknow believes this drug could help take control over the novel coronavirusIvermectin is an anti-parasitic drug that has been beneficial in treating various kinds of tropical diseases, including onchocerciasis, helminthiases, and scabies
  • The creators of the drug, Omura and Campbell were even awarded the Nobel Prize for physiology and medicine in 2015
  • Addressing the lack of available clinical data on Ivermectin, Kant states that around 8 trials out of the total 66 trials are currently underway in India, with none showing any major side effects

India Times,

14 April, 2021

 

With COVID-19 taking a tiger grasp on the lives of the people in India and around the world, experts around the world, apart from the vaccines by Pfizer, Moderna or AstraZeneca (and others) have been looking for existing medications that can help.

ivermectin drug covid-19

Reuters

We’ve seen experts recommend Hydroxychloroquine during the early days of the pandemic, followed by Remdesivir that helped in reducing the multiplication of COVID-19 in the patient’s body in extreme cases. 

Another drug that was commonly used in Australia for the treatment of COVID-19 was Ivermectin. This drug is now being commonly used in various states in India. And Dr Surya Kant Tripathi, Head, Respiratory Medicine Department at King George Medical University in Lucknow believes this drug could help take control over the novel coronavirus

Ivermectin: the wonder drug? 

Ivermectin is an anti-parasitic drug that has been beneficial in treating various kinds of tropical diseases, including onchocerciasis, helminthiases, and scabies. However, it was first created for veterinary use. 

Discovered in the 1960s by Satoshi Omura, a microbiologist at Tokyo’s Kitasako Institute & William Campbell from New Jersey, a culture of the bacteria dubbed Streptomyces avermictilis was proven effective against worms. Its active component dubbed avermectin was later chemically modified that made it safer and more effective and finally the compound was named Ivermectin, commercialised for animal use in 1981. 

ivermectin drug covid-19

AFP

Campbell later urged his colleagues to use Ivermectin for potential treatment against onchocerciasis — a disease caused by worms and transmitted in flies causing blindness in people living in Sub-Saharan Africa. Initial trials in Senegal showed a positive response and in 1987 it was approved for human use, with over 3.7 billion doses donated by Merck labs distributed across the world.

India giving Ivermectin to its COVID-19 patients 

Indian medical institutions have started giving COVID-19 patients Ivermectin off-label. Medical institutions across the nation are also giving the drug as a prophylaxis against the novel coronavirus. 

This is being seen in several states of the nation including Uttar Pradesh and Maharashtra. Dr Surya Kant Tripathi, in a conversation with Financial Express has revealed that the drug has been in use for over nine months now without major side effects being reported. 

ivermectin drug covid-19

Dr Surya Kant Tripathi

Currently, it is being provided to patients under home isolation and patients experiencing mild cases of the disease. Kant claims that this drug has anti-viral, anti-parasitic, anti-cancer and even anti-HIV properties. 

He was one of the many experts from India who had submitted a white paper on Ivermectin last year to WHO, emphasising that the drug was seen to reduce the replication rate of the novel coronavirus by a thousand times. Only after this paper, did the UP government start to recommend the drug to its citizens. 

Addressing the lack of available clinical data on Ivermectin, Kant states that around 8 trials out of the total 66 trials are currently underway in India, with none showing any major side effects

Another study published in PLoS One, conducted by AIIMS Bhubaneswar has shown that Two-dose ivermectin prophylaxis was associated with a 73 percent reduction of SARS-CoV-2 infection among healthcare workers for the following month. 

WHO disapproved use of ivermectin on COVID-19 patients 

On April 3, 2021, WHO made an announcement stating it recommended against the use of anti-parasite drug Ivermectin in patients with COVID-19. It only permits the use of the drug in patients who are a part of clinical trials, as of now there isn’t enough data that shows its benefits. 

According to WHO, 66 trials of Ivermectin have been registered, with over 60,000 participants. It indicated that more data on its impact on the pandemic could soon arrive. This notification came soon after European Medicines Agency warned medical practitioners from using this drug. The drug has also been recommended to not be used for COVID-19 cases by the US’s FDA. 

 

Dr Surya Kant said it was only after Australia started including Ivermectin in its protocol for COVID-19 treatment significantly, the WHO started thinking about the drug.

WHO, Ivermectin, Dr Surya kant tripathiWorld Health Organisation/Dr Surya Kant Tripathi. (Image Source: Reuters/Screengrab)Financial Express (India)

14 April, 2021

 

The World Health Organisation (WHO) recently recommended that antiparasitic drug Ivermectin must be used to treat COVID-19 patients within the clinical trials only. The WHO sighted lack of conclusive data behind this recommendation, which is applicable to “patients with COVID-19 of any disease severity.” Despite this, some states – including Uttar Pradesh and Maharashtra – are using the drug off-label for not only the treatment of coronavirus patients but also as prophylaxis against COVID-19. Ivermectin, also referred to as a ‘wonder drug’ by many, is usually used to treat parasitic infections like onchocerciasis (river blindness), trichuriasis, scabies, strongyloidiasis, and other diseases caused by soil-transmitted helminthiasis. But, Uttar Pradesh has prescribed it as part of a protocol to treat mild and moderate cases of COVID-19.

Moreover, rapid response teams in the state have been ordered to distribute Ivermectin to people under home isolation. The teams of doctors who assess asymptomatic patients are even asking primary and secondary contacts of confirmed cases to take this drug in order to prevent any possible infection. When asked about the decision to continue the usage of the drug for the treatment of COVID-19, Dr Surya Kant Tripathi – Head, Respiratory Medicine Department, King George Medical University, Lucknow – told Financial Express Online that Ivermectin is being used both for the treatment of coronavirus patients and as prophylaxis for COVID-19 for more than nine months without any major side effects being reported.

“The drug is being majorly used for the treatment of COVID-19 when patients are under home isolation and also in all mild cases of the disease. It is true that we have not used the drug in severe cases. But this is also a fact that even healthcare workers shifted from the prophylaxis of hydroxychloroquine to Ivermectin. This is because we observed that 17 per cent of healthcare workers using hydroxychloroquine developed one or another kind of side effects,” Dr Surya Kant – who is also national vice chairman of IMA-AMS – said.

It must be noted that Dr Surya Kant, along with some other health experts of India, wrote a white paper on Ivermectin last year and it was displayed on the website of the World Health Organization. Dr Surya Kant also emphasized that this drug reduces the replication rate of the infection by several thousand times. It was only after this white paper when Uttar Pradesh government started using the drug. UP was the first state to use Ivermectin for treatment of COVID-19 and it has been extensively used since then, the doctor of KGMU said.

“Not only Uttar Pradesh, governments of West Bengal, Maharashtra, and Assam too included Ivermectin in their protocol for the treatment of COVID-19,” he added.

When asked about the lack of clinical trial data on Ivermectin, Dr Surya Kant said that over 40 such trials are underway, and not one has reported any major side effects yet. “More than 40 clinical trials are underway, including eight in India. This includes the most prestigious institute in India i.e. AIIMS Delhi. The trial underway at AIIMS is also on five different types of doses of Ivermectin, which is a very important issue. So, all kinds of trials are underway. My whitepaper was published in the month of July 2020. In the whitepaper, 19 Indian experts have contributed. They collected and compiled all data available on Ivermectin since 1981, when the drug was introduced to the world. Both researchers (William C. Campbell of US and Satoshi Ōmura from Japan) who discovered this drug won the 2015 Nobel Prize in Physiology or Medicine for discovering this drug. It has got more than four properties – anti-viral, anti-parasitic, anti-cancer, and even anti-HIV. This is a wonderful drug, low cost, widely available and used for last 40 years throughout the world.”

He went on to say that anti-viral drug remdesivir has failed drastically. “All trials are saying that this drug is not effective in the treatment of COVID-19, rather it is complicating and resulting in mortality of patients. At so many centers, remdesivir trails were stopped. Also, remdesivir is costing minimum of Rs 5,000 per vial.

Dr Surya Kant said it was only after Australia started including Ivermectin in its protocol for COVID-19 treatment significantly, the WHO started thinking about the drug.

“Australia has triple therapy protocol for COVID-19 which includes Ivermectin, Zinc, and Doxycycline. This is being widely used in Australia and it controlled the spread of COVID-19 very well. Bangladesh too has successfully implemented this protocol of Ivermectin. It was only after Australia successfully controlled the disease, WHO started talking about this ‘wonder drug’,” he said.

When asked whether he would approach the WHO over its recommendation, the national vice chairman of IMA – AMS said he has not read the complete recommendations of the WHO. “But I will go through it and will definitely write back to them,” Dr Surya Kant said.

Dr Surya Kant said it was only after Australia started including Ivermectin in its protocol for COVID-19 treatment significantly, the WHO started thinking about the drug.

WHO, Ivermectin, Dr Surya kant tripathi

World Health Organisation/Dr Surya Kant Tripathi. (Image Source: Reuters/Screengrab)The World Health Organisation (WHO) recently recommended that antiparasitic drug Ivermectin must be used to treat COVID-19 patients within the clinical trials only. The WHO sighted lack of conclusive data behind this recommendation, which is applicable to “patients with COVID-19 of any disease severity.” Despite this, some states – including Uttar Pradesh and Maharashtra – are using the drug off-label for not only the treatment of coronavirus patients but also as prophylaxis against COVID-19. Ivermectin, also referred to as a ‘wonder drug’ by many, is usually used to treat parasitic infections like onchocerciasis (river blindness), trichuriasis, scabies, strongyloidiasis, and other diseases caused by soil-transmitted helminthiasis. But, Uttar Pradesh has prescribed it as part of a protocol to treat mild and moderate cases of COVID-19.

India’s ‘Miraculous’ Ivermectin COVID Treatment Is Only $3 Per Person

22 January, 2021

While the United States continues its aggressive military roll-out of novel, expensive and dangerous pharmaceutical vaccines, India has developed a “miraculously” effective and safe COVID-19 treatment kit which costs merely $2.65 per person and has helped put the nation’s case and fatality rates in “steep decline.”

Australian Professor: Ivermectin ‘Amazingly Successful’ in Killing Coronavirus

08 August 2020

gloved hand holding a bottle of the medicine
A health worker shows a bottle of Ivermectin. (LUIS ROBAYO/AFP via Getty Images)

An Australian drug known as Ivermectin, which is already in use throughout the world to treat parasitic conditions, is showing great results in killing coronavirus in studies involving patients, according to Sky News.

“Because I’m involved in developing these in the U.S. where all the patients are, there are a number of studies that are amazingly successful. We’re talking close to 100%. In fact, we haven’t seen a result yet under 100%. It looks like corona is very simple to kill,”  Professor Thomas Borody, medical director of Australia’s Center for Digestive Disease. “It’s available as a prescription medication. You wouldn’t use it alone … but you add two other things to it such as doxycycline and zinc.”

Ivermectin is already approved by the FDA and is on the World Health Organization’s list of model list of essential medicines.

One thought on “From India- THIS IS MAJOR

Leave a Reply

Your email address will not be published.

Wordpress Social Share Plugin powered by Ultimatelysocial
RSS